Dow Down0.15% Nasdaq Down0.23%

Sarepta Therapeutics, Inc. (SRPT)

-NasdaqGS
21.20 Down 0.28(1.30%) 9:58AM EDT - Nasdaq Real Time Price
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.4
Mean Recommendation (last week):2.4
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:37.94
Median Target:36.50
High Target:63.00
Low Target:13.00
No. of Brokers:16

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Aug 1, 2014OppenheimerInitiated Outperform
Jul 29, 2014WBB SecuritiesUpgradeSpeculative BuyBuy
Jan 21, 2014NeedhamUpgradeHoldBuy
Nov 26, 2013WBB SecuritiesUpgradeSellSpeculative Buy
Nov 13, 2013Deutsche BankDowngradeBuyHold
Nov 13, 2013NeedhamDowngradeBuyHold
Oct 30, 2013FBR CapitalInitiated Mkt Perform
Sep 6, 2013StifelInitiated Buy
Apr 22, 2013NeedhamInitiated Buy
Apr 4, 2013Robert W. BairdInitiated Outperform

More Upgrades & Downgrades for SRPT

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy4433
Buy4445
Hold6655
Underperform1100
Sell1111

Data provided by Thomson/First Call


Currency in USD.